AL, F., A, M., RRAK, S., F, J., L, G., T, T., . . . VH, K. (2024). Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: A retrospective analysis. The Lancet. Oncology, 25(2), 198. https://doi.org/10.1016/S1470-2045(23)00560-0
Chicago Style (17th ed.) CitationAL, Frei, et al. "Multiplex Analysis of Intratumoural Immune Infiltrate and Prognosis in Patients with Stage II-III Colorectal Cancer from the SCOT and QUASAR 2 Trials: A Retrospective Analysis." The Lancet. Oncology 25, no. 2 (2024): 198. https://doi.org/10.1016/S1470-2045(23)00560-0.
MLA (9th ed.) CitationAL, Frei, et al. "Multiplex Analysis of Intratumoural Immune Infiltrate and Prognosis in Patients with Stage II-III Colorectal Cancer from the SCOT and QUASAR 2 Trials: A Retrospective Analysis." The Lancet. Oncology, vol. 25, no. 2, 2024, p. 198, https://doi.org/10.1016/S1470-2045(23)00560-0.